VU University Medical Center Amsterdam is the university hospital affiliated with the Vrije Universiteit Amsterdam. It is rated one of the best academic medical centers in the country in terms of patient care and research.

There are 733 beds in VU Medisch Centrum.

During the past decade, VU Medisch Centrum conducted 282 clinical trials. In the 10-year time frame, 282 clinical trials started and 76 clinical trials were completed, i.e. on average, 27% percent of trials that started reached the finish line to date. In the past 5 years, 118 clinical trials started and 55 clinical trials were completed. i.e. 46.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "VU Medisch Centrum" #1 sponsor was "Amsterdam UMC, location VUmc" with 56 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 44 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 28 trials sponsored, "Celgene" with 18 trials sponsored and "Janssen Research & Development, LLC" with 18 trials sponsored. Other sponsors include 290 different institutions and companies that sponsored additional 145 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "VU Medisch Centrum" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 19 trials as a collaborator, "Amsterdam UMC, location VUmc" with 15 trials as a collaborator, "Dutch Cancer Society" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 9 trials as a collaborator and "Erasmus Medical Center" with 8 trials as a collaborator. Other collaborators include 371 different institutions and companies that were collaborators in the rest 256 trials.

According to Clinical.Site data, the most researched conditions in "VU Medisch Centrum" are "Multiple Myeloma" (24 trials), "Lung Cancer" (16 trials), "Pulmonary Arterial Hypertension" (14 trials), "Breast Cancer" (10 trials) and "Multiple Sclerosis" (9 trials). Many other conditions were trialed in "VU Medisch Centrum" in a lesser frequency.

Most popular intervention types in "VU Medisch Centrum" are "Drug" (297 trials), "Other" (64 trials), "Procedure" (48 trials), "Biological" (36 trials) and "Device" (33 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (68 trials), "Dexamethasone" (17 trials), "radiation therapy" (13 trials), "Daratumumab" (11 trials) and "Lenalidomide" (11 trials). Other intervention names were less common.

The vast majority of trials in "VU Medisch Centrum" are 421 trials for "All" genders, 23 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 167 active trials in "VU Medisch Centrum". 5 are not yet recruiting, 98 are recruiting, 59 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 187 completed trials in VU Medisch Centrum, 2 suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in VU Medisch Centrum, 45 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 184 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 26 trials, and there were also 66 trials that are defined as “Not Applicable".

VU Medisch Centrum has several departments that took part in Clinical trials: "Amsterdam UMC, Locatie VUMC; Neurology" - 3 trials, "Academic Medical Center - University of Amsterdam, Dept. of Gastroenterology" - 2 trials